| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-5793(90)81322-F |
| P8608 | Fatcat ID | release_l2lt7afgffbivack7buqvzayvq |
| P698 | PubMed publication ID | 2253778 |
| P5875 | ResearchGate publication ID | 20901850 |
| P50 | author | Catherine Grillon | Q47451297 |
| P2093 | author name string | W Voelter | |
| E Hannappel | |||
| M Lenfant | |||
| D Schott | |||
| J L Morgat | |||
| J Bakala | |||
| K Rieger | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | haematopoietic system | Q4241494 |
| P304 | page(s) | 30-34 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system | |
| P478 | volume | 274 |
| Q72059305 | 51 Peptidyl-asp metalloendopeptidase |
| Q82287552 | AcSDKP: a new potential marker of malignancy of the thyroid gland |
| Q40824663 | Acetyl-seryl-aspartyl-lysyl-proline is a novel natural cell cycle regulator of renal cells |
| Q37351830 | Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline |
| Q36818204 | Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4. |
| Q43923223 | Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline |
| Q38076770 | Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design |
| Q43980638 | Application of capillary electrophoresis in peptide research |
| Q30651272 | Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds |
| Q50571979 | C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. |
| Q89565308 | Cardiovascular diseases in survivors of childhood cancer |
| Q42060681 | Cell-cycle-regulated expression of thymosin beta 4 in thymocytes |
| Q36811290 | Characterization of natural peptides from bovine tissue using capillary electrophoresis, high performance liquid chromatography, matrix-assisted laser desorption ionization, and Edman degradation |
| Q37666013 | Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke |
| Q27736100 | Conformation of thymosin beta 9 in water/fluoroalcohol solution determined by NMR spectroscopy |
| Q73568293 | Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs |
| Q86646243 | Distribution and biological activity ofβ-thymosins |
| Q41165790 | Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues |
| Q32184250 | Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. |
| Q43862175 | Effect of enkephalins on bone marrow cells |
| Q37962590 | Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors |
| Q28280776 | Expression of thymosin beta-4 and related genes in developing human brain |
| Q41080520 | Feedback inhibitors in normal and tumor tissues |
| Q33652254 | Formation of acetyl-Ser-Asp-Lys-Pro, a new regulator of the hematopoietic system, through enzymatic processing of thymosin beta 4. |
| Q41676673 | Growth inhibitors in haemopoiesis and leukaemogenesis. |
| Q30863976 | Identification of novel genes involved in the development of the sword and gonopodium in swordtail fish |
| Q67539406 | Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells |
| Q42831735 | Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline |
| Q50658722 | Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering. |
| Q28367770 | Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension |
| Q36333123 | Modulation of the interaction between G-actin and thymosin beta 4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamics |
| Q40535007 | N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo. |
| Q27008887 | N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes |
| Q36806165 | Neurotrophic roles of the beta-thymosins in the development and regeneration of the nervous system |
| Q38053074 | Pathophysiology of the aging kidney and therapeutic interventions |
| Q82443643 | Quantification of N-acetyl-seryl-aspartyl-lysyl-proline in hemodialysis patients administered angiotensin-converting enzyme inhibitors by stable isotope dilution liquid chromatography–tandem mass spectrometry |
| Q33489476 | Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study. |
| Q38465432 | Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration |
| Q40883545 | Small actin-binding proteins: the beta-thymosin family |
| Q35291020 | The actin-sequestering protein thymosin beta-4 is a novel target of hypoxia-inducible nitric oxide and HIF-1α regulation |
| Q38224257 | The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis |
| Q42793542 | The complete sequences of trout (Salmo gairdneri) thymosin beta 11 and its homologue thymosin beta 12 |
| Q42485457 | The interaction of (1-4)-fragment of thymosin beta 4 with calmodulin-sensitive cAMP phosphodiesterase from hypothalamus |
| Q28186145 | The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function |
| Q36818229 | Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium |
| Q42504195 | Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. |
| Q38908425 | Thymosin β4 Gene Expression in Leukemic Cells |
| Q42365639 | Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline |
| Q39654494 | Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis |
| Q28299857 | beta-Thymosins |
| Q33943182 | beta-Thymosins, small acidic peptides with multiple functions |
Search more.